(Press-News.org) Immune checkpoint pathways regulate T cell function and play pivotal roles in the treatment of both cancer and autoimmune diseases. One key component of these pathways is Lymphocyte Activation Gene 3 (LAG-3)—a classical immunosuppressive receptor that has long posed unresolved questions regarding its biological mechanisms.
In a new study published on June 30 in Cell, researchers from the Institute of Biophysics of the Chinese Academy of Sciences, the Grossman School of Medicine at New York University, and the School of Medicine at Zhejiang University have systematically demonstrated that LAG-3 inhibits T cell activity by positioning itself in close proximity to the T cell receptor (TCR) complex, rather than by simply binding to a ligand.
This study is the first to systematically reveal the conditional activation mechanism of the inhibitory receptor LAG-3, which is regulated by its classical ligand, Major Histocompatibility Complex class II (MHC-II). Instead of functioning through simple ligand binding, LAG-3 depends on MHC-II-mediated spatial proximity to the T cell receptor (TCR), enabling cis co-localization with the TCR complex and subsequent phase separation, thereby effectively suppressing CD4+ T cells.
This discovery challenges the traditional understanding of immune checkpoint activation mechanisms, particularly that of LAG-3. The strong dependence of LAG-3 on spatial and contextual activation suggests that it is not easily triggered in vivo. However, this very feature presents a unique opportunity for the precise modulation of autoreactive T cells in autoimmune diseases.
Based on this mechanism, the researchers developed an innovative bispecific T cell silencer (BiTS) antibody that simultaneously targets LAG-3 and TCR. This antibody selectively regulates pathogenic T cells expressing LAG-3 and shows significant therapeutic efficacy in multiple autoimmune disease animal models.
The study introduces the concept of "cis-proximity-dependent immune checkpoint," highlighting that LAG-3 does not function as a conventional receptor reliant solely on ligand engagement. Instead, its activity is tightly controlled by its spatial proximity to the TCR within the immune synapse.
This conditional mechanism helps explain the limited efficacy of LAG-3 monotherapies in cancer treatment, while also providing a rationale for its potential use in treating autoimmune diseases.
The researchers further propose a novel therapeutic strategy of "cis-inhibitory bispecific antibodies" for autoimmune treatment. This strategy has great potential to drive the development of next-generation precision immunotherapies that target pathogenic T cells, opening new avenues in autoimmune disease intervention.
END
New bispecific antibody exploits immune receptor proximity to control autoimmunity
2025-07-07
ELSE PRESS RELEASES FROM THIS DATE:
New precision medicine approach identifies a promising ovarian cancer treatment
2025-07-07
A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to a preclinical study led by Weill Cornell Medicine investigators. The research reveals a promising strategy against this hard-to-treat malignancy, and more generally demonstrates a powerful new approach for the identification of effective regimens to treat genetically diverse cancers.
Ovarian cancer is genetically diverse in the sense that it can be driven by mutations in many different genes. This complicates the standard strategy of developing drugs to target common driver mutations. In the study, published July 7 in Cell Reports Medicine, the researchers applied a ...
‘Space ice’ is less like water than we thought
2025-07-07
“Space ice” contains tiny crystals and is not, as previously assumed, a completely disordered material like liquid water, according to a new study by scientists at UCL (University College London) and the University of Cambridge.
Ice in space is different to the crystalline (highly ordered) form of ice on Earth. For decades, scientists have assumed it is amorphous (without a structure), with colder temperatures meaning it does not have enough energy to form crystals when it freezes.
In the new study, ...
Trends in US children’s mortality, chronic conditions, obesity, functional status, and symptoms
2025-07-07
About The Study: The health of U.S. children has worsened across a wide range of health indicator domains over the past 17 years. The broad scope of this deterioration highlights the need to identify and address the root causes of this fundamental decline in the nation’s health.
Corresponding Author: To contact the corresponding author, Christopher B. Forrest, MD, PhD, email forrestc@chop.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2025.9855)
Editor’s Note: Please see the article for additional information, including other authors, author ...
Cannabidiol and liver enzyme level elevations in healthy adults
2025-07-07
About The Study: In this randomized double-blind clinical trial of healthy adults administered cannabidiol (CBD), 5 mg/kg/d for 28 days, 8 (5.6%) experienced liver enzyme level elevations and 7 (4.9%) met protocol defined criteria for potential drug-induced liver injury. Participants did not experience clinical symptoms related to liver function during this 28-day study and hepatic enzymes returned to normal within 1 to 2 weeks following discontinuation. The findings of this study underscore the need for further investigation on the long-term effects of CBD use, its impact on various populations, and the safety of lower doses ...
Scientists Unveil AI-powered universal strategy for protein engineering
2025-07-07
A team of Chinese researchers led by Prof. GAO Caixia from the Institute of Genetics and Developmental Biology (IGDB) of the Chinese Academy of Sciences has developed a groundbreaking method that could transform the field of protein engineering. The new approach, called AI-informed Constraints for protein Engineering (AiCE), enables rapid and efficient protein evolution by integrating structural and evolutionary constraints into a generic inverse folding model—without the need to train specialized artificial intelligence (AI) models.
The study, published in Cell on July 7, addresses many of the challenges ...
Eye cells "rewire" themselves when vision begins to fail
2025-07-07
Scientists at the Jules Stein Eye Institute at the David Geffen School of Medicine at UCLA have discovered that certain retinal cells can rewire themselves when vision begins to deteriorate in retinitis pigmentosa, a genetic eye disease that leads to progressive blindness. In a study using mouse models, researchers found that rod bipolar cells, neurons that normally receive signals from rods that provide night vision, can form new functional connections with cones that provide daytime vision when their usual partners stop working. The study appears in Current Biology.
Why it matters
Retinitis pigmentosa affects millions of people worldwide and is a leading cause of inherited ...
Cambridge study shows stem cell grafts can restore myelin in MS lesions in mice
2025-07-07
A study led by Cambridge researchers has shed light on how neural stem cell grafts could help restore myelin in the central nervous system. The findings suggest that neural stem cell-based therapies hold promise as a potential treatment for chronic demyelinating disorders, particularly progressive multiple sclerosis.
Multiple sclerosis (MS) is an autoimmune disease where the body's immune system mistakenly attacks the central nervous system, leading to the destruction of myelin, the protective sheath surrounding nerve fibres. This damage is a leading cause of neurological disability in young adults.
In the early stages ...
Mediterranean bacteria may harbor new mosquito solution
2025-07-07
Highlights:
Mosquitoes that carry pathogens often develop resistance to insecticides.
Biopesticides offer an ecologically friendly way to control the pests and mitigate resistance, but options are limited.
Researchers recently identified bacteria in Crete producing metabolites that quickly kill mosquito larvae in lab tests.
The compounds might be useful for the development of new biopesticides, though developing the right formulations and delivery method remains a challenge.
Washington, D.C.—Mosquito-borne diseases kill more than 700,000 people every year, according to the World Health Organization, ...
New study maps four key pathways to Alzheimer’s disease
2025-07-07
UCLA Health researchers have identified four distinct pathways that lead to Alzheimer's disease by analyzing electronic health records, offering new insights into how the condition develops over time rather than from isolated risk factors.
The study, published in the journal eBioMedicine, examined longitudinal health data from nearly 25,000 patients in the University of California Health Data Warehouse and validated findings in the nationally diverse All of Us Research Program. Unlike previous ...
Voracious honey bees threaten the food supply of native pollinators
2025-07-07
The majority of the earth’s plant species, including our crop plants, rely on the services of animal pollinators in order to reproduce. Honey bees and other pollinating insects annually contribute billions of dollars to the U.S. economy, and are responsible for nearly a third of the food that ends up on our tables. Our modern agricultural industry is so reliant on honey bees that humans have introduced them worldwide, and in many cases, they have escaped human management and risen to prominence in natural ecosystems as non-native, ...